Companies researching Invokamet
Invokamet is a prescription medication that combines the SGLT2 inhibitor canagliflozin with the biguanide metformin to treat type 2 diabetes.
0
companies
Frequently asked questions
Invokamet is a prescription medication that combines the SGLT2 inhibitor canagliflozin with the biguanide metformin to treat type 2 diabetes.
0
companies
Frequently asked questions